SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Centocor ( CNTO )
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
965 13 0 CNTO
Emcee:  PawPr Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
815 CNBC has been mentioning CNTO all morning and WSJ also has a favorable report tHenry Niman-11/9/1998
814 See TNF Inhibitor table on New Therapeutics page at biocognizance.comHenry Niman-11/9/1998
813 Check tonights wsj.com. CNTO study results to be reported at Cardiology conferDon Edgerton-11/9/1998
812 CNTO well covered in BBRS review of AHA meeting. Details linked to the CardiovHenry Niman-11/8/1998
811 sort of, kind of, not really...xemilofiban should be more of a competitor to boDavid S.-11/5/1998
810 The biocognizance.com site is down again. The BBRS and Bear Stearns reviewsHenry Niman-11/5/1998
809 Ciao, Alfredo: Re: < ...future IL-6 and IL-12 stories and great potential FNS-11/5/1998
808 FNS, grazie tante. The arthritis data from Centocor are great. I think however Alfredo Nova-11/5/1998
807 CNTO is rallying at the expense of MTC today. Monsanto Scales Back Heart Drugjopawa-11/4/1998
806 Like I said, we've broke out on a weekly basis and Morgan Stanley is sayingFNS-11/2/1998
805 What's up (or why is CNTO up 3)? I can't find any news. EdwinEdwin Slonim-11/2/1998
804 Alfredo, <<I think Remicade will be good for rheumatoid arthritis. Saw aFNS-10/31/1998
803 To all: bought a lot of Centocor at 37. Will hold after comments of robust ReopAlfredo Nova-10/30/1998
802 Thanks for the posts. Would be nice to close out this month on a good note;, iFNS-10/29/1998
801 Here's a more detailed report. Comments anyone? Thursday October 29, 4:42 jopawa-10/29/1998
800 I saw this on the wires. Obviously it accounts for the action today. Centocor jopawa-10/29/1998
799Message 5875922 although earnings estimates for cnto are going south for the wiDavid S.-10/22/1998
798 David, You are correct - this was a US re-hash of the earlier European presentBiomaven-10/12/1998
797 considering that the data had ALREADY BEEN REPORTED IN AUGUST, it is strange thDavid S.-10/12/1998
796 Peter: Remicade is officially released ...nice move up again. Hope QTRLY earniFNS-10/12/1998
795 Very nice looking ReoPro study: biz.yahoo.com PeterBiomaven-10/9/1998
794 Peter: <<Good news for ReoPro - doctors are apparently sticking with theFNS-9/30/1998
793 Corr was weak today on a H&Q downgrade, citing weak sales of Integrilin, anBiomaven-9/30/1998
792 Peter: <<... and the ReoPro/Retavase combination becomes the standard theFNS-9/27/1998
791 Well maybe one reason CNTO paid a healthy chunk for Retavase is that they know Biomaven-9/27/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):